fda bpc-157 category 2 bulk drug substance compounding list substances Major peptide regulatory news this week. The The FDA scheduled a hearing
Description
Research demonstrates inhibition of NNMT reduces adipocyte differentiation and increases metabolic rate in preclinical models
In Zieve D, Ogilvie I, et al
S100a8 silencing attenuates inflammation, oxidative stress and apoptosis in BV2 cells induced by oxygen-glucose deprivation and reoxygenation by upregulating GAB1 expression
It extends the GLOW blend with the addition of KPV for anti-inflammatory signaling research
